• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脉搏波速度变化与临床结局风险:一项基于中国社区人群的队列研究。

Changes in baPWV and the risk of clinical outcomes: a cohort study of Chinese community-based population.

机构信息

Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.

Department of Cardiology, Kailuan Hospital, North China University of Science and Technology, Tangshan, China.

出版信息

J Hum Hypertens. 2024 May;38(5):460-466. doi: 10.1038/s41371-024-00902-9. Epub 2024 Feb 27.

DOI:10.1038/s41371-024-00902-9
PMID:38413723
Abstract

It has not been fully investigated whether improved arterial stiffness (AS) can reduce the clinical outcomes risk in community population-based study. In this prospective study, a total of 5247 individuals with abnormal AS (at baseline) and repeated brachial-ankle pulse wave velocity (baPWV) measurement before 2018 years were enrolled from the Kailuan Study. According the second baPWV measurement, we divided the participants into two groups, improved AS (defined as transfer elevated AS status to normal) and persistent AS (defined as maintaining elevated AS status). The outcome was a composite event of stroke, myocardial infraction, and all-cause mortality. We used Cox proportional hazards regression to examine the association between AS status at the follow-up and the subsequent outcome. During a median of 5.2 years follow-up, we observed 413 end point events. After adjusted for potential confounders, comparing with the persistent AS group, individuals in the improved AS group had a 43% (hazard ratio [HR], 0.57; 95% confidence interval [CI] 0.35-0.94) decreased the risk of the primary composite events. We also found a baPWV decrease of 1 m/s was associated with a 3% decreased risk (HR, 0.97; 95% CI 0.94-0.99) for primary composite events. We further demonstrated that younger than 60 years, non-smoker, non-hypertension, and non-diabetes were associated with improved the AS status. In conclusion, improving AS status may reduce the risk of clinical events. In the future, more research should be performed to explore the target for improving the AS status.

摘要

尚未充分研究社区人群中动脉僵硬度(AS)改善是否能降低临床结局风险。在这项前瞻性研究中,共纳入了 5247 名 AS 异常(基线时)且在 2018 年前重复进行了肱踝脉搏波速度(baPWV)测量的个体。根据第二次 baPWV 测量结果,我们将参与者分为两组,改善的 AS(定义为将升高的 AS 状态转为正常)和持续的 AS(定义为维持升高的 AS 状态)。结局是卒中、心肌梗死和全因死亡率的复合事件。我们使用 Cox 比例风险回归分析来研究随访时的 AS 状态与随后结局之间的关系。在中位 5.2 年的随访期间,我们观察到 413 例终点事件。在校正了潜在混杂因素后,与持续的 AS 组相比,改善的 AS 组发生主要复合事件的风险降低了 43%(风险比 [HR],0.57;95%置信区间 [CI],0.35-0.94)。我们还发现,baPWV 降低 1m/s 与主要复合事件风险降低 3%(HR,0.97;95%CI,0.94-0.99)相关。我们进一步表明,年龄小于 60 岁、不吸烟、无高血压和无糖尿病与改善 AS 状态相关。总之,改善 AS 状态可能降低临床事件风险。未来需要开展更多研究以探索改善 AS 状态的目标。

相似文献

1
Changes in baPWV and the risk of clinical outcomes: a cohort study of Chinese community-based population.脉搏波速度变化与临床结局风险:一项基于中国社区人群的队列研究。
J Hum Hypertens. 2024 May;38(5):460-466. doi: 10.1038/s41371-024-00902-9. Epub 2024 Feb 27.
2
The association between brachial-ankle pulse-wave velocity and adverse cardiovascular events in 5719 community participants a prospective cohort study.5719 名社区参与者前瞻性队列研究中臂踝脉搏波速度与不良心血管事件的关系。
J Hypertens. 2023 Sep 1;41(9):1411-1419. doi: 10.1097/HJH.0000000000003481. Epub 2023 Jun 8.
3
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.减少或无麸质饮食对心血管疾病一级预防的影响。
Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
5
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
6
Elevated pulse wave velocity as a marker of arterial stiffness and its association with mortality in US adults.脉搏波速度升高作为动脉僵硬度的标志物及其与美国成年人死亡率的关联。
Sci Rep. 2025 Jul 2;15(1):23026. doi: 10.1038/s41598-025-07198-w.
7
Smoking cessation for secondary prevention of cardiovascular disease.戒烟对心血管疾病二级预防的作用。
Cochrane Database Syst Rev. 2022 Aug 8;8(8):CD014936. doi: 10.1002/14651858.CD014936.pub2.
8
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
9
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
10
Dietary interventions for recurrent abdominal pain in childhood.儿童复发性腹痛的饮食干预措施
Cochrane Database Syst Rev. 2017 Mar 23;3(3):CD010972. doi: 10.1002/14651858.CD010972.pub2.

引用本文的文献

1
The Association of Circulating Bone Morphogenetic Protein 9 and Arterial Stiffness in Hypertensive Patients.高血压患者循环骨形态发生蛋白9与动脉僵硬度的关联
J Clin Hypertens (Greenwich). 2025 Jun;27(6):e70086. doi: 10.1111/jch.70086.
2
QKD interval as a noninvasive method for evaluation of atherosclerosis.量子密钥分发间隔作为评估动脉粥样硬化的一种非侵入性方法。
Hypertens Res. 2024 Nov;47(11):3275-3276. doi: 10.1038/s41440-024-01879-1. Epub 2024 Sep 11.

本文引用的文献

1
SPARTE Study: Normalization of Arterial Stiffness and Cardiovascular Events in Patients With Hypertension at Medium to Very High Risk.SPARTE 研究:中至高心血管风险的高血压患者的动脉僵硬度正常化和心血管事件。
Hypertension. 2021 Sep;78(4):983-995. doi: 10.1161/HYPERTENSIONAHA.121.17579. Epub 2021 Aug 30.
2
Joint association of modifiable lifestyle and metabolic health status with incidence of cardiovascular disease and all-cause mortality: a prospective cohort study.生活方式的可调节因素与代谢健康状况联合与心血管疾病和全因死亡率的关系:一项前瞻性队列研究。
Endocrine. 2022 Jan;75(1):82-91. doi: 10.1007/s12020-021-02832-9. Epub 2021 Aug 3.
3
Hypertension, Arterial Stiffness, and Clinical Outcomes: A Cohort Study of Chinese Community-Based Population.
高血压、动脉僵硬与临床结局:一项基于中国社区人群的队列研究。
Hypertension. 2021 Aug;78(2):333-341. doi: 10.1161/HYPERTENSIONAHA.121.17131. Epub 2021 Jun 14.
4
Diabetes modifies the association of prehypertension with cardiovascular disease and all-cause mortality.糖尿病改变了高血压前期与心血管疾病和全因死亡率的关联。
J Clin Hypertens (Greenwich). 2021 Jun;23(6):1221-1228. doi: 10.1111/jch.14246. Epub 2021 Apr 4.
5
Triglyceride-glucose index is associated with the risk of myocardial infarction: an 11-year prospective study in the Kailuan cohort.甘油三酯-葡萄糖指数与心肌梗死风险相关:一项在开滦队列中进行的 11 年前瞻性研究。
Cardiovasc Diabetol. 2021 Jan 12;20(1):19. doi: 10.1186/s12933-020-01210-5.
6
Arterial Stiffness Preceding Diabetes: A Longitudinal Study.动脉僵硬度与糖尿病的关系:一项纵向研究。
Circ Res. 2020 Dec 4;127(12):1491-1498. doi: 10.1161/CIRCRESAHA.120.317950. Epub 2020 Sep 28.
7
Allisartan Isoproxil Improves Endothelial Function and Vascular Damage in Patients with Essential Hypertension: A Single-Center, Open-Label, Randomized Controlled Trial.奥美沙坦异丙酯可改善原发性高血压患者的血管内皮功能和血管损伤:一项单中心、开放性、随机对照试验。
Adv Ther. 2020 Aug;37(8):3551-3561. doi: 10.1007/s12325-020-01413-y. Epub 2020 Jun 24.
8
Association of Age of Onset of Hypertension With Cardiovascular Diseases and Mortality.高血压发病年龄与心血管疾病及死亡率的关系。
J Am Coll Cardiol. 2020 Jun 16;75(23):2921-2930. doi: 10.1016/j.jacc.2020.04.038.
9
2018 ESC/ESH Guidelines for the management of arterial hypertension.2018年欧洲心脏病学会/欧洲高血压学会动脉高血压管理指南。
Eur Heart J. 2018 Sep 1;39(33):3021-3104. doi: 10.1093/eurheartj/ehy339.
10
Changes in proteinuria and the risk of myocardial infarction in people with diabetes or pre-diabetes: a prospective cohort study.蛋白尿变化与糖尿病或糖尿病前期人群心肌梗死风险:一项前瞻性队列研究。
Cardiovasc Diabetol. 2017 Aug 15;16(1):104. doi: 10.1186/s12933-017-0586-7.